The Value of Circulating microRNAs for Diagnosis and Prediction of Preeclampsia: a Meta-analysis and Systematic Review
Authors:
- 24 November 2021
- journal article
- review article
- Published by Springer Nature in Reproductive Sciences
- Vol. 29 (11) , 3078-3090
Abstract
Preeclampsia (PE) is one of the main causes of maternal death worldwide, but our understanding of the molecular characteristics of disease progression is limited. In this meta-analysis, we aimed to assess the value of peripheral blood microRNAs (miRNAs) as diagnostic and predictive markers of PE. We screened PubMed, Web of Science, and Embase databases; searched articles about “miRNAs and PE” up to November 30, 2020; and conducted biological information and subgroup analysis. We used QUADAS-2 (quality assessment of diagnostic accuracy studies-2) to evaluate the included articles by two independent reviewers, calculated the combined diagnostic and predictive indicators using the random effects model, explored the sources of potential heterogeneity through subgroup analysis, and evaluated publication bias using Deeks’ funnel plot asymmetry test using Stata 14.0 and Review Manager 5.3 software. Forty-three miRNAs from 15 studies, including 2042 healthy controls and 2685 PE patients, had a pooled sensitivity of 0.86 (95% CI: 0.81–0.90), specificity of 0.89 (95% CI: 0.85–0.92), and an AUC of 0.94 (95% CI: 0.91–0.96). Moreover, before 20 weeks of gestation, the combined sensitivity was 0.86 (95% CI: 0.75–0.92), and the specificity was 0.90 (95% CI: 0.83–0.95), which indicated that some of the circulating miRNAs had changed significantly before the clinical symptoms appeared in PE patients. Circulating miRNAs have high diagnostic and predictive accuracy and may be used as non-invasive biomarkers for the diagnosis and prediction of PE. However, a large sample prospective study is still needed.Keywords
Funding Information
- Natural Science Foundation of Shandong Province (ZR2019MH127)
- National Natural Science Foundation of China (82071667)
- Key Research and Development Plan of Shandong Province (2019GSF108106)
This publication has 27 references indexed in Scilit:
- MiR-942 decreased before 20 weeks gestation in women with preeclampsia and was associated with the pathophysiology of preeclampsia in vitroClinical and Experimental Hypertension, 2017
- First trimester screening of circulating C19MC microRNAs and the evaluation of their potential to predict the onset of preeclampsia and IUGRPLOS ONE, 2017
- First-trimester maternal cell microRNA is a superior pregnancy marker to immunological testing for predicting adverse pregnancy outcomeJournal of Reproductive Immunology, 2015
- Exosome and Exosomal MicroRNA: Trafficking, Sorting, and FunctionGenomics, Proteomics & Bioinformatics, 2015
- First Trimester Pbmc Microrna Predicts Adverse Pregnancy OutcomeAmerican Journal of Reproductive Immunology, 2014
- The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHPPregnancy Hypertension, 2014
- Emerging Role of MicroRNAs in Cardiovascular DiseasesCirculation Journal, 2014
- Pregnancy-associated miRNA-clustersJournal of Reproductive Immunology, 2013
- Integrated genome analysis suggests that most conserved non-coding sequences are regulatory factor binding sitesNucleic Acids Research, 2012
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011